Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali.

Drissa Coulibaly Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Mali, Bamako, Mali, West Africa.

Search for other papers by Drissa Coulibaly in
Current site
Google Scholar
PubMed
Close
,
Dapa A Diallo Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Mali, Bamako, Mali, West Africa.

Search for other papers by Dapa A Diallo in
Current site
Google Scholar
PubMed
Close
,
Mahamadou A Thera Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Mali, Bamako, Mali, West Africa.

Search for other papers by Mahamadou A Thera in
Current site
Google Scholar
PubMed
Close
,
Alassane Dicko Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Mali, Bamako, Mali, West Africa.

Search for other papers by Alassane Dicko in
Current site
Google Scholar
PubMed
Close
,
Ando B Guindo Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Mali, Bamako, Mali, West Africa.

Search for other papers by Ando B Guindo in
Current site
Google Scholar
PubMed
Close
,
Abdoulaye K Koné Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Mali, Bamako, Mali, West Africa.

Search for other papers by Abdoulaye K Koné in
Current site
Google Scholar
PubMed
Close
,
Yacouba Cissoko Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Mali, Bamako, Mali, West Africa.

Search for other papers by Yacouba Cissoko in
Current site
Google Scholar
PubMed
Close
,
Seydou Coulibaly Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Mali, Bamako, Mali, West Africa.

Search for other papers by Seydou Coulibaly in
Current site
Google Scholar
PubMed
Close
,
Abdoulaye Djimdé Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Mali, Bamako, Mali, West Africa.

Search for other papers by Abdoulaye Djimdé in
Current site
Google Scholar
PubMed
Close
,
Kirsten Lyke Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Mali, Bamako, Mali, West Africa.

Search for other papers by Kirsten Lyke in
Current site
Google Scholar
PubMed
Close
,
Ogobara K Doumbo Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Mali, Bamako, Mali, West Africa.

Search for other papers by Ogobara K Doumbo in
Current site
Google Scholar
PubMed
Close
, and
Christopher V Plowe Malaria Research and Training Center, Faculty of Medicine, Pharmacy and Dentistry, University of Mali, Bamako, Mali, West Africa.

Search for other papers by Christopher V Plowe in
Current site
Google Scholar
PubMed
Close
Restricted access

Treating malaria before immunizing has been standard in malaria vaccine field trials. To assess the impact of this practice on subsequent infection and disease incidence, we conducted a randomized cohort study in Bandiagara, Mali. Subjects received a treatment dose of sulfadoxine-pyrimethamine (SP) or no treatment at the beginning of the transmission season. Cumulative and age-specific incidence of clinical episodes was similar between the 2 groups, but SP treatment delayed the median time to first clinical episode from 38.5 to 68 days, and after this initial period of protection, disease incidence in the SP group quickly surpassed the incidence in the untreated group. Parasite densities during disease episodes were lower in the SP group. SP was chosen as the drug for initial parasite clearance for the following reasons: 1) it has been used in previous vaccine trials; 2) our studies have found it to have >99% efficacy in treating uncomplicated malaria in Mali compared to 85-90% efficacy for chloroquine in this area; 3) SP is the approved second-line antimalarial agent in Mali; and 4) its single-dose regimen ensures compliance when treatment is directly observed.

Save